CHEK1 and breast cancer: Importantly, CHEK1 and PLK1 were found to be poor prognostic biomarkers for the survival of breast cancer patients (Supplementary Figure 3), further supporting that enhanced DNA damage repair mechanisms in cancer cells play a catastaltic role in efficient radiotherapy (Pavlopoulou et al., 2016, 2017).